Use of a Fixed, Body Weight-Unadjusted Loading Dose of Unfractionated Heparin for Extracorporeal Cardiopulmonary Resuscitation
A major complication of Extracorporeal cardiopulmonary resuscitation (ECPR) is bleeding; however, the optimal initial heparin dose and activated coagulation time (ACT) remain unknown. The aim of this study was to assess the appropriateness of our initial anticoagulation protocol.
Successful Use of a Military Haemostatic Agent in Patients Undergoing Extracorporeal Circulatory Assistance and Delayed Sternal Closure
We report the successful control of bleeding in two patients who underwent post-cardiotomy extracorporeal circulatory support (ECMO) and then developed life-threatening bleeding due to severe coagulopathy.
Management of Anticoagulation and Hemostasis for Pediatric Extracorporeal Membrane Oxygenation
Compared to in situ vascular physiology where pro and anti-hemostatic processes are in balance to maintain hemostasis, the use of ECMO in a critically ill child increases the risk of hemorrhagic or thromboembolic events due to a perturbation in the balance inherent of this complex system.
Safe Anticoagulation When Heart and Lungs are “On Vacation”
Circulation and oxygenation of blood outside the body is commonly required during complex surgical interventions involving coronary pulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO).
Updates on Coagulation Management in Cardiac Surgery
Perioperative coagulopathy is regularly observed in patients undergoing cardiovascular surgery and is associated with massive bleeding, increased need for blood products transfusion, and re-exploration for surgical hemostasis.
Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading
The joint European Society of Cardiology and European Association of Cardio-Thoracic Surgery (ESC/EACTS) guidelines on myocardial revascularization collect and summarize the evidence regarding decision-making, diagnostics, and therapeutics in various clinical scenarios of coronary artery disease, including elective, urgent, and emergency settings.
European Society of Cardiology (ESC) Congress Report from Barcelona 2014
The Annual Congress of the European Society of Cardiology (ESC) was held in Barcelona from 30th August to 3rd September 2014.
Canadian Cardiovascular Society Position Statement on the Management of Thoracic Aortic Disease
This Canadian Cardiovascular Society position statement aims to provide succinct perspectives on key issues in the management of thoracic aortic disease (TAD).
Hemodynamic Monitoring in Nigerian Patients Undergoing High-risk Surgery
Hemodynamic monitoring (HM) and optimization of cardiac output and parameters of dynamic fluid responsiveness is said to improve perioperative outcome in high-risk surgical patients (HRSP).
Is Cold or Warm Blood Cardioplegia Superior for Myocardial Protection
A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the use of warm or cold blood cardioplegia has superior myocardial protection.
Evidence-Based Medicine and Myocardial Protection – Where is the Evidence
The goal of this analysis is to describe current practices in cardioplegia and to point out the lack of quality human research and subsequent publications that prevent best practices from being utilized.
Blood Transfusions After Pediatric Cardiac Operations: A North American Multicenter Prospective Study
This study characterized anemia development and red blood cell transfusions in the pediatric intensive care unit (PICU) after cardiac operations.